Vγ9Vδ2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies

ISSN： 1970-5557

Source： Oncology Reviews, Vol.4, Iss.4, 2010-12, pp. : 211-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer

By Kuroda Hirohiko Saito Hiroaki Ikeguchi Masahide

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 433-439

Springer Publishing Company

Access to resources Recommend Favorite

HEMATOLOGIC MALIGNANCIES

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 33-47

Informa Healthcare

Access to resources Recommend Favorite

Targeting Pseudomonas exotoxin to hematologic malignancies

By Kreitman R.J. Pastan I.

Seminars in Cancer Biology, Vol. 6, Iss. 5, 1995-10 ,pp. : 297-306

Academic Press

Access to resources Recommend Favorite

Development of the farnesyltransferase inhibitor tipifarnib for therapy of hematologic malignancies

By Karp Judith E Lancet Jeffrey E

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 719-731

Future Medicine

Access to resources Recommend Favorite

Targeting Sphingosine-1-Phosphate in Hematologic Malignancies

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 9, 2011-11 ,pp. : 794-798

Bentham Science Publishers

Access to resources Recommend Favorite